Methodological reviews of economic evaluations in health care: what do they target?
- 454 Downloads
Introduction and objectives
An increasing number of published studies of economic evaluations of health technologies have been reviewed and summarized with different purposes, among them to facilitate decision-making processes. These reviews have covered different aspects of economic evaluations, using a variety of methodological approaches. The aim of this study is to analyze the methodological characteristics of the reviews of economic evaluations in health care, published during the period 1990–2010, to identify their main features and the potential missing elements. This may help to develop a common procedure for elaborating these kinds of reviews.
We performed systematic searches in electronic databases (Scopus, Medline and PubMed) of methodological reviews published in English, period 1990–2010. We selected the articles whose main purpose was to review and assess the methodology applied in the economic evaluation studies. We classified the data according to the study objectives, period of the review, number of reviewed studies, methodological and non-methodological items assessed, medical specialty, type of disease and technology, databases used for the review and their main conclusions. We performed a descriptive statistical analysis and checked how generalizability issues were considered in the reviews.
We identified 76 methodological reviews, 42 published in the period 1990–2001 and 34 during 2002–2010. The items assessed most frequently (by 70 % of the reviews) were perspective, type of economic study, uncertainty and discounting. The reviews also described the type of intervention and disease, funding sources, country in which the evaluation took place, type of journal and author’s characteristics. Regarding the intertemporal comparison, higher frequencies were found in the second period for two key methodological items: the source of effectiveness data and the models used in the studies. However, the generalizability issues that apparently are creating a growing interest in the economic evaluation literature did not receive as much attention in the reviews of the second period. The remaining items showed similar frequencies in both periods.
Increasingly more reviews of economic evaluation studies aim to analyze the application of methodological principles, and offer summaries of papers classified by either diseases or health technologies. These reviews are useful for finding literature trends, aims of studies and possible deficiencies in the implementation of methods of specific health interventions. As no significant methodological improvement was clearly detected in the two periods analyzed, it would be convenient to pay more attention to the methodological aspects of the reviews.
KeywordsEconomic evaluation Review Methodology
JEL ClassificationI 18
- 3.Drummond, M.F., O′Brien, B.J., Stoddart, G.L., Sculpher, M.F., Torrance, G.W.: Methods for the Economic Evaluation of Health Care Programs, 2nd edn. Oxford University Press, New York (1997)Google Scholar
- 5.Australia Commonwealth Department of Health, Housing and Community Services: Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefit Advisory Committee, Canberra (November 1995)Google Scholar
- 6.Canadian Coordination Office for Health Technology Assessment: Guidelines for economic evaluation of pharmaceuticals, 2nd edn, Ottawa (1997)Google Scholar
- 10.Collège des Economistes de la Santé. Recommandations de bonnes practiques des methods d′evaluation économique des strategiques therapeutiques: La Lettre du Collège, numero special: Evaluation économique des strategies therapeutiques (April 1997)Google Scholar
- 11.Gruppe, H.K.: Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation—Revidierte Fassung des Hannoveraner Konsens. Gesundheitsökonomie & Qualitätsmanagement 4(3), A62–A65 (1999)Google Scholar
- 12.Gold, M.R., Siegel, J.E., Russell, L.B., Weinstein, M.G.: Cost Effectiveness in Health and Medicine, 1st edn. Oxford University Press, New York, NY (1996)Google Scholar
- 14.NHS Centre for Reviews and Dissemination: Making Cost-Effectiveness Information Accessible: the NHS Economic Evaluation Database Project—CRD guidance for reporting critical summaries of economic evaluations. NHS Centre for Reviews and Dissemination, University of York, York (1996)Google Scholar
- 15.Health Economic Evaluation Database (HEED): Office of Health Economics and the International Federation of Pharmaceutical Manufacturers Associations (OHE-IFPMA). John Wiley & Sons, Ltd. London. On November 1, (2006)Google Scholar
- 20.Brazier, J., Deverill, M., Green, C.: A review of the use of health status measures in economic evaluation. Health Technol. Assess. 3, 1–164 (1999)Google Scholar
- 28.Earle, C.C., Chapman, R.H., Baker, C.S., Bell, C.M., Stone, P.W., Sandberg, E.A., Neumann, P.J.: Systematic overview of cost utility assessment in oncology. J. Clin. Oncol. 15(18), 3302–3317 (2000)Google Scholar
- 44.Pritchard, C.: What do we know about the economic evaluations literature? A review of HEED. J. Drug Assess. 4, 1–70 (2001)Google Scholar
- 58.Lee, J.T., Sanchez, L.A.: Interpretation of cost-effective and soundness of economic evaluations in the pharmacy literature. Australian Journal of Health Promotion 48, 2622–2627 (1991)Google Scholar
- 75.Elixhauser, A., Halpern, M., Schmier, J., Luce, B.R.: Health care CBA and CEA from 1991 to 1996: an updated bibliography. Medical Care 36(5), MS 1–9, MS 18–47 (1998)Google Scholar
- 76.Elixhauser, A., Luce, B.R., Taylor, B.R., Reblando, J.: Health care CBA/CEA: an update on the growth and composition of the literature. Med Care 31(7suppl), JS1–11, JS18–149 (1993)Google Scholar
- 78.Uegaki, K., de Bruijne, M.C., Lambeek, L., Anema, J.R., van der Beek, A.J., van Mechelen, W., van Tulder, M.W.: Economic evaluations of occupational health interventions from a corporate perspective—a systematic review of methodological quality. Scand. J. Work Environ. Health 36(4), 273–288 (2010)PubMedCrossRefGoogle Scholar
- 81.Anonychuk, A.M., Tricco, A.C., Bauch, C.T., Pham, B., Gilca, V., Duval, B., John-Baptiste, A., Woo, G., Krahn, M.: Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. Pharmacoeconomics 26(1), 17–32 (2008)PubMedCrossRefGoogle Scholar
- 82.Schwappach, D.L.B, Boluarte, T.A.: HEE-GER: a systematic review of German economic evaluations of health care published 1990–2004. BMC Health Services Research 7 art. No. 7 (2007)Google Scholar
- 85.Van Veen, N.H.J., McNamee, P., Richardus, J.H., Smith, W.C.S.: Cost-effectiveness of intervention to prevent disability in leprosy: a systematic review. PLoS ONE 4(2), art. no. e4548 (2009)Google Scholar